جستجوی مقالات مرتبط با کلیدواژه "global" در نشریات گروه "پزشکی"

Strict adherence to safety precautions and, most importantly, social distancing and isolation of people infected with the Coronavirus disease-19 (COVID-19) virus have considerably affected the daily life activities of individuals and overshadowed their routine lifestyle. We conducted a systematic review to provide evidence-based information for clinicians, health policymakers, and social workers in developing useful interventions to effectively mitigate the adverse impacts of the pandemic on people’s life and health condition.

In this systematic review and meta-analysis, studies assessing quality of life (QOL) among the population during the COVID-19 pandemic were searched in four main databases and Google Scholar from the onset of the epidemic to May 2021 with Mesh terms of quality of life and Covid-19.

We included 23058 people who participated in 33 studies; the total quality of life score was estimated at 59.45 (95% CI, 56.33-62.58). Based on the analysis, for each year added to participants’ age, their quality of life score was reduced by -0.3%. Furthermore, a significant association between gender and QOL was affirmed, indicating a more favorable condition among men. The highest score of QOL was reported in AMRO at 66.77 (95% CI, 60.55-73) and WPRO at 64.79 (95% CI, 59.30-70.28), respectively, while SEARO with 47.95 (95% CI, 47.67-48.23) got the lowest score.

Our review robustly recommends the necessity for community health promotion programs to be implemented in vulnerable community segments and adds corresponding knowledge to the existing literature about the status of quality of life in people with different socio-demographic characteristics living in different regions worldwide.

The reduction of preventable deaths from non-communicable diseases, including cancers, is one of the main targets of universal health coverage. Not only there is a shortage of financial resources for universal health coverage for cancer patients in many countries, but also there are many challenges in the continuity and the quality of care. There are disparities rooted in both providers’ and patients’ behavior at the time of care. Unmet needs for information on treatment and prognosis, inadequate cost coverage of care, and inadequate support for other living costs are contributing factors to poor prognosis in cancer patients, especially in cases with advanced stages and those living in low-income countries. There is a need for a comprehensive, holistic approach to the care of cancer patients considering the patients’ socioeconomic and cultural status and the institutional status of the providers.

 Although the current literature suggests the significant impact of the COVID-19 pandemic on nosocomial infections, evidence is still scarce in this regard.

The present study aimed to systematically review the current literature to estimate the prevalence of hospital-acquired infections (HAIs) and their determinants during the COVID-19 pandemic.

A comprehensive search was conducted via electronic databases such as EMBASE, Google Scholar, Scopus, PubMed, and Web of Science from the onset of the COVID-19 pandemic until the end of June 2021. To estimate the pooled prevalence of nosocomial infections, the random effects model was used.

The prevalence of HAIs during the COVID-19 pandemic was estimated at 15% (95% CI: 9 - 24). COVID-19 infection accounted for the highest infection rate in patients with HAIs (63%; 95% CI: 43 - 75), followed by bloodstream infections (39%; 95% CI: 56 - 24). Among the common organisms that infected patients with HAIs, coronavirus had the highest rate (63%; 95% CI: 43 - 75), followed by Enterococci and Enterococcus, respectively. In addition, positive significant correlations were observed between the prevalence of nosocomial infections, age, and length of hospital stay (P < 0.05).

According to the results, nosocomial infections are an important consequence of the COVID-19 pandemic, particularly in the elderly and high-risk populations with prolonged hospital stay. Therefore, the early detection of infected individuals could be a key step toward improving the quality of response to the current pandemic.

Behcet’s disease is a chronic fatal illness with a relapsing remitting nature and significant organ-threatening morbidity and mortality. The aim of this research was to examine studies which were conducted on investigation of prevalence of quality of life among patients with Behcet’s disease.

A total of 13 articles were extracted from four main databases including PubMed, EMBASE, Scopus, and Web of Science from the onset of 2000 to January 2021. All studies published in English with the purpose of examining quality of life (QOL) among patients with BD or investigating its main determinants were included.

Totally, 1137 BD patients participated in 13 studies. Based on random effect analysis, the total score of physical health-related QOL was 46.7 (95% CI=41.26 to 52.13) and the total score of mental health-related QOL was 49.01 (95% CI=43.83 to 54.18) representing a moderate level of QOL among BD patients. Furthermore, weighted effect size analyses showed a significant correlation between QOL and variables such as patients’ age, gender, disease duration and depression (pvalue: 0.00).

As the symptoms of BD worsen over time, patients confront with more severe body pain, mobility restrictions, and difficulties in chewing, eating, speaking and swallowing which negatively affect social interactions of patients and reduce their QOL. Furthermore, depression was proved to act as a deteriorating factor for HRQOL among BD patients. Thus, patients need to be psychologically supported by a specialized team and be informed during the course of treatment to gain useful information about the disease, treatment approaches and coping strategies.